Table 1. No ABBT vs. TAU differences in demographic or clinical characteristics at baseline (n=34).

	Descriptive statistics		Comparison between groups at baseline
	TAU (n = 17)	AABT (n = 17)	t or χ2 (p = )
Age, mean (SD)	34.6 (10.9)	34.3 (12.0)	0.07 (.947)
Male, n (%)	13 (81.3%)	14 (82.4%)	0.01 (.935)
Non-Latino White, n (%)	5 (31.3%)	3 (17.7%)	0.83 (.362)
Single, n (%)	8 (50.0%)	10 (58.8%)	2.06 (.560)
Employed part- or full-time, n (%)	8 (50.0%)	12 (70.6%)	9.12 (.057)
Days HIV+, mean (SD)	39.6 (71.2)	59.1 (88.7)	-0.69 (.494)
Method of HIV transmission
Men who have sex with men, n (%)	13 (81.3%)	10 (58.8%)	0.31 (.579)
Heterosexual, n (%)	3 (18.8%)	7 (41.2%)	1.96 (.161)
Intravenous drug use, n (%)	1 (6.3%)	0 (0.0%)	1.10 (.295)
Unknown, n (%)	1 (6.3%)	0 (0.0%)	1.10 (.295)
CD4+ (cells/mm3), mean (SD)	351.9 (255.2)	319.7 (124.7)	0.47 (.645)
HIV Stigmatization, mean (SD)	27.8 (5.1)	23.8 (6.1)	2.03 (.051)
Experiential avoidance of HIV, mean (SD)	21.3 (10.6)	24.5 (14.6)	-0.73 (.469)
HIV Disclosure willingness, mean (SD)	18.1 (4.9)	20.5 (5.6)	-1.32 (.197)
# of HIV disclosures, mean (SD)	3.8 (5.8)	6.9 (10.3)	-1.09 (.285)
Perceived social support, mean (SD)	5.1 (1.6)	5.2 (1.3)	-0.15 (.884)